Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction

Human Molecular Genetics

Volumn 15, Issue SUPPL. 2, 2006, Pages

  Gelb, Bruce D ^a   Tartaglia, Marco ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAS PROTEIN;

ARTICLE; BIOCHEMISTRY; CARDIOFACIOCUTANENOUS SYNDROME; CHICK EMBRYO; CONTROLLED STUDY; COSTELLO SYNDROME; CYTOLOGY; DROSOPHILA; GENETIC DISORDER; HEREDITY; LEOPARD SYNDROME; LEUKEMIA; MISSENSE MUTATION; NONHUMAN; NOONAN SYNDROME; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHICK EMBRYO; DROSOPHILA; GENES, RAS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEOPARD SYNDROME; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MUTATION; NOONAN SYNDROME; PROTEIN CONFORMATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE-PHOSPHATASE;

ANIMALIA;

EID: 33749003166     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl197     Document Type: Article

References (49)

1. Noonan, J.A. (1968) Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am. J. Dis. Child., 116, 373-380.
2. Tartaglia, M., Mehler, E.L., Goldberg, R., Zampino, G., Brunner, H.G., Kremer, H., van der Burgt, I., Crosby, A.H., Ion, A., Jeffery, S. et al. (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet., 29, 465-468.
3. Tartaglia, M., Martinelli, S., Stella, L., Bocchinfuso, G., Flex, E., Cordeddu, V., Zampino, G., Burgt, I., Palleschi, A., Petrucci, T.C. et al. (2006) Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am. J. Hum. Genet., 78, 279-290.
4. Keilhack, H., David, F.S., McGregor, M., Cantley, L.C. and Neel, B.G. (2005) Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. J. Biol. Chem., 280, 30984-30993.
5. Tartaglia, M., Martinelli, S., Cazzaniga, G., Cordeddu, V., Iavarone, I., Spinelli, M., Palmi, C., Carta, C., Pession, A., Arico, M. et al. (2004) Genetic evidence for lineage- and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood, 104, 307-313.
6. Tartaglia, M., Niemeyer, C.M., Fragale, A., Song, X., Buechner, J., Jung, A., Hahlen, K., Hasle, H., Licht, J.D. and Gelb, B.D. (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet., 34, 148-150.
7. Mohi, M.G., Williams, I.R., Dearolf, C.R., Chan, G., Kutok, J.L., Cohen, S., Morgan, K., Boulton, C., Shigematsu, H., Keilhack, H. et al. (2005) Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell, 7, 179-191.
8. Schubbert, S., Lieuw, K., Rowe, S.L., Lee, C.M., Li, X., Loh, M.L., Clapp, D.W. and Shannon, K.M. (2005) Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood, 106, 311-317.
9. Carta, C., Pantaleoni, F., Bocchinfuso, G., Stella, L., Vasta, I., Sarkozy, A., Digilio, C., Palleschi, A., Pizzuti, A., Grammatico, P. et al. (2006) Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype. Am. J. Hum. Genet., 79, 129-135.
10. Schubbert, S., Zenker, M., Rowe, S.L., Boll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.E. et al. (2006) Germline KRAS mutations cause Noonan syndrome. Nat. Genet., 38, 331-336.
11. Friday, B.B. and Adjei, A.A. (2005) K-ras as a target for cancer therapy. Biochim. Biophys. Acta, 1756, 127-144.
12. Plowman, S.J., Williamson, D.J., O'Sullivan, M.J., Doig, J., Ritchie, A.M., Harrison, D.J., Melton, D.W., Arends, M.J., Hooper, M.L. and Patek, C.E. (2003) While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Mol. Cell. Biol., 23, 9245-9250.
13. Mitin, N., Rossman, K.L. and Der, C.J. (2005) Signaling interplay in Ras superfamily function. Curr. Biol., 15, R563-R574.
14. Barbacid, M. (1987) RAS genes. Ann. Rev. Biochem., 56, 779-827.
15. Herrmann, C. (2003) Ras-effector interactions: After one decade. Curr. Opin. Struct. Biol., 13, 122-129.
16. Wittinghofer, A. and Waldmann, H. (2000) Ras: A molecular switch involved in tumor formation. Angew Chem., 39, 4192-4214.
17. Araki, T., Mohi, M.G., Ismat, F.A., Bronson, R.T., Williams, I.R., Kutok, J.L., Yang, W., Pao, L.I., Gilliland, D.G., Epstein, J.A. et al. (2004) Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat. Med., 10, 849-857.
18. Oishi, K., Gaengel, K., Krishnamoorthy, S., Kamiya, K., Kim, I.K., Ying, H., Weber, U., Perkins, L.A., Tartaglia, M., Mlodzik, M. et al. (2006) Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations. Hum. Mol. Genet., 15, 543-553.
19. Perkins, L.A., Larsen, I. and Perrimon, N. (1992) corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell, 70, 225-236.
20. Lu, X., Perkins, L.A. and Perrimon, N. (1993) The torso pathway in Drosophila: A model system to study receptor tyrosine kinase signal transduction. Dev., (Suppl.), 47-56.
21. Perrimon, N., Lu, X., Hou, X.S., Hsu, J.C., Melnick, M.B., Chou, T.B. and Perkins, L.A. (1995) Dissection of the Torso signal transduction pathway in Drosophila. Mol. Reprod. Dev., 42, 515-522.
22. Cleghon, V., Feldmann, P., Ghiglione, C., Copeland, T.D., Perrimon, N., Hughes, D.A. and Morrison, D.K. (1998) Opposing actions of CSW and RasGAP modulate the strength of Torso RTK signaling in the Drosophila terminal pathway. Mol. Cell, 2, 719-727.
23. Ghiglione, C., Perrimon, N. and Perkins, L.A. (1999) Quantitative variations in the level of MAPK activity control patterning of the embryonic termini in Drosophila. Dev. Biol., 205, 181-193.
24. Perkins, L.A., Johnson, M.R., Melnick, M.B. and Perrimon, N. (1996) The nonreceptor protein tyrosine phosphatase corkscrew functions in multiple receptor tyrosine kinase pathways in Drosophila. Dev. Biol., 180, 63-81.
25. Firth, L., Manchester, J., Lorenzen, J.A., Baron, M. and Perkins, L.A. (2000) Identification of genomic regions that interact with a viable allele of the Drosophila protein tyrosine phosphatase corkscrew. Genetics, 156, 733-748.
26. Baker, N.E. and Rubin, G.M. (1992) Ellipse mutations in the Drosophila homologue of the EGF receptor affect pattern formation, cell division, and cell death in eye imaginal discs. Dev. Biol., 150, 381-396.
27. Krenz, M., Yutzey, K.E. and Robbins, J. (2005) Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling. Circ. Res., 97, 813-820.
28. Chang, C.P., Neilson, J.R., Bayle, J.H., Gestwicki, J.E., Kuo, A., Stankunas, K., Graef, I.A. and Crabtree, G.R. (2004) A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell, 118, 649-663.
29. Legius, E., Schrander-Stumpel, C., Schollen, E., Pulles-Heintzberger, C., Gewillig, M. and Fryns, J.P. (2002) PTPN11 mutations in LEOPARD syndrome. J. Med. Genet., 39, 571-574.
30. Digilio, M.C., Conti, E., Sarkozy, A., Mingarelli, R., Dottorini, T., Marino, B., Pizzuti, A. and Dallapiccola, B. (2002) Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am. J. Hum. Genet., 71, 389-394.
31. Ion, A., Tartaglia, M., Song, X., Kalidas, K., Van Der Burgt, I., Shaw, A.C., Ming, J.E., Zampino, G., Zackai, E.H., Dean, J.C. et al. (2002) Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome. Hum. Genet., 111, 421-427.
32. Troger, B., Kutsche, K., Bolz, H., Luttgen, S., Gal, A., Almassy, Z., Caliebe, A., Freisinger, P., Hobbiebrunken, E., Morlot, M. et al. (2003) No mutation in the gene for Noonan syndrome, PTPN11, in 18 patients with Costello syndrome. Am. J. Med. Genet., 121A, 82-84.
33. Kavamura, M.I., Pomponi, M.G., Zollino, M., Lecce, R., Murdolo, M., Brunoni, D., Alchorne, M.M., Opitz, J.M. and Neri, G. (2003) PTPN11 mutations are not responsible for the cardiofaciocutaneous (CFC) syndrome. Eur. J. Hum. Genet., 11, 64-68.
34. Tartaglia, M., Cotter, P.D., Zampino, G., Gelb, B.D. and Rauen, K.A. (2003) Exclusion of PTPN11 mutations in Costello syndrome: Further evidence for distinct genetic etiologies of Noonan, cardio-facio-cutaneous, and Costello syndromes. Clin. Genet., 63, 423-426.
35. Gorlin, R.J., Anderson, R.C. and Moller, J.H. (1971) The Leopard (multiple lentigines) syndrome revisited. Birth Defects Orig. Artic. Ser., 7, 110-115.
36. Yoshida, R., Nagai, T., Hasegawa, T., Kinoshita, E., Tanaka, T. and Ogata, T. (2004) Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome. Am. J. Med. Genet., 130A, 432-434.
37. Sarkozy, A., Conti, E., Seripa, D., Digilio, M.C., Grifone, N., Tandoi, C., Fazio, V.M., Di Ciummo, V., Marino, B., Pizzuti, A. et al. (2003) Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J. Med. Genet., 40, 704-708.
38. Sarkozy, A., Obregon, M.G., Conti, E., Esposito, G., Mingarelli, R., Pizzuti, A. and Dallapiecola, B. (2004) A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/LEOPARD syndrome and Noonan-like/multiple giant cell lesion syndrome. Eur. J. Hum. Genet., 12, 1069-1072.
39. Sarkozy, A., Conti, E., Digilio, M.C., Marino, B., Morini, E., Pacileo, G., Wilson, M., Calabro, R., Pizzuti, A. and Dallapiccola, B. (2004) Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J. Med. Genet., 41, e68.
40. Digilio, M.C., Sarkozy, A., Pacileo, G., Limongelli, G., Marino, B. and Dallapiccola, B. (2006) PTPN11 gene mutations: Linking the Gln510Glu mutation to the 'LEOPARD syndrome phenotype'. Eur J Pediatr. (Epub ahead of print May 30, 2006).
41. Hanna, N., Montagner, A., Lee, W.H., Miteva, M., Vidal, M., Vidaud, M., Parfait, B. and Raynal, P. (2006) Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1. FEBS Lett., 580, 2477-2482.
42. Kontaridis, M.I., Swanson, K.D., David, F.S., Barford, D. and Neel, B.G. (2006) PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J. Biol. Chem., 281, 6785-6792.
43. Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., Ohashi, H., Tanaka, Y., Filocamo, M., Kato, K., Suzuki, Y., Kure, S. et al. (2005) Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet., 37, 1038-1040.
44. Colby, W.W., Hayflick, J.S., Clark, S.G. and Levinson, A.D. (1986) Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes. Mol. Cell. Biol., 6, 730-734.
45. Estep, A.L., Tidyman, W.E., Teitell, M.A., Cotter, P.D. and Rauen, K.A. (2006) HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy. Am. J. Med. Genet. A, 140, 8-16.
46. Gripp, K.W., Lin, A.E., Stabley, D.L., Nicholson, L., Scott, C.I., Jr., Doyle, D., Aoki, Y., Matsubara, Y., Zackai, E.H., Lapunzina, P. et al. (2006) HRAS mutation analysis in Costello syndrome: Genotype and phenotype correlation. Am. J. Med. Genet. A, 140, 1-7.
47. Kerr, B., Delrue, M.A., Sigaudy, S., Perveen, R., Marche, M., Burgelin, I., Stef, M., Tang, B., Eden, O.B., O'Sullivan, J. et al. (2006) Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J. Med Genet., 43, 401-405.
48. Niihori, T., Aoki, Y., Nammi, Y., Neri, G., Cave, H., Verloes, A., Okamoto, N., Hennekam, R.C., Gillessen-Kaesbach, G., Wieczorek, D. et al. (2006) Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat. Genet., 38, 294-296.
49. Rodriguez-Viciana, P., Tetsu, O., Tidyman, W.E., Estep, A.L., Conger, B.A., Cruz, M.S., McCormick, F. and Rauen, K.A. (2006) Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science, 311, 1287-1290.